Chiesi SAS: Clinical Trials

2 unknown, 1 not yet recruiting. .

Follow Chiesi SAS: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence Life-Cycle Pharma Tacrolimus, Kidney transplantation - Chronic Renal Disease		Not yet recruiting	Chiesi SAS	165	2025-05-01	2025-05-07
Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study Beclometasone/Formoterol/Glycopyrronium 88 µg/5 µg/9 µg DPI (Trimbow® 88 µg/5 µg/9 µg in NEXThaler device) - COPD		Unknown	Chiesi SAS	500	2023-08-01	2024-03-13
A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes Non-interventional - ASTHMA		Unknown	Chiesi SAS	300	2023-03-03	2023-07-06

Conditions studied

Asthma (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Renal Insufficiency, Chronic (1)  ·  Respiratory Tract Diseases (1)

Interventions

Beclomethasone (1)  ·  Formoterol Fumarate (1)  ·  Glycopyrrolate (1)  ·  Kidney Transplantation (1)

Countries

France (3)